{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:34:09Z","timestamp":1785818049177,"version":"3.56.0"},"reference-count":64,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T00:00:00Z","timestamp":1122940800000},"content-version":"vor","delay-in-days":1858,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:p><jats:bold>Summary: <\/jats:bold>  <jats:italic>Purpose<\/jats:italic>: To compare the frequency of seizures and status epilepticus and their response to first\u2010line drugs in patients with idiopathic generalized epilepsies receiving carba\u2010mazepine or phenytoin to those receiving other drugs or no treatment.<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>: We performed a retrospective chart review of all cases of idiopathic generalized epilepsies treated by the authors between 1985 and 1994. We compared seizure frequency and mean intravenous benzodiazepine dose required to control absence status epilepticus, intraindividually in subjects on carba\u2010mazepine or phenytoin before and after discontinuation of these compounds, and interindividually to subjects without treatment or receiving other drugs.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: Bouts of absence or tonic\u2010clonic status epilepticus and seizures in subjects treated with phenytoin or carbamaze\u2010pine at therapeutic concentrations were considerably more frequent and proved intractable to treatment with valproic acid or benzodiazepines, compared with a cohort of subjects also with idiopathic generalized epilepsies, but naive to, or receiving sub\u2010therapeutic or therapeutic doses of other agents.<\/jats:p><jats:p> <jats:italic>Conclusions<\/jats:italic>: Our observations strongly suggest that therapeutic concentrations of phenytoin and carbamazepine exacerbate idiopathic generalized epilepsies. Subjects in whom absence is one of the seizure types seem at a particularly high risk for responding paradoxically. These findings underscore the value of accurate classification of seizures and particularly the syndromic approach to diagnosis and point to the potential for iatrogenic complications with indiscriminate use of antiseizure drugs.<\/jats:p>","DOI":"10.1111\/j.1528-1157.2000.tb00258.x","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T06:35:48Z","timestamp":1123050948000},"page":"887-894","source":"Crossref","is-referenced-by-count":71,"title":["Refractory Idiopathic Absence Status Epilepticus: A Probable Paradoxical Effect of Phenytoin and Carbamazepine"],"prefix":"10.1111","volume":"41","author":[{"given":"Ivan","family":"Osorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill N.","family":"Peltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,2]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198206033062205"},{"key":"e_1_2_1_3_2","first-page":"377","article-title":"General principles of treatment: responsive and intractable status epilepticus in adults","volume":"34","author":"Treiman DM.","year":"1983","journal-title":"Adv Neurol"},{"key":"e_1_2_1_4_2","first-page":"61","article-title":"Petit mal status","volume":"34","author":"Porter RJ","year":"1983","journal-title":"Adv Neurol"},{"key":"e_1_2_1_5_2","first-page":"465","article-title":"Benzodiazepines: efficacy in status epilepticus","volume":"34","author":"Tassinari CA","year":"1983","journal-title":"Adv Neurol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1972.tb04565.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb05903.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1973.tb03965.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1996.tb00047.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01267.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01268.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1984.tb03441.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1989.tb05824.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(88)90083-5"},{"key":"e_1_2_1_15_2","first-page":"95","volume-title":"Idiopathic generalized epilepsies: clinical, experimental and genetics aspects","author":"Thomas P","year":"1994"},{"key":"e_1_2_1_16_2","first-page":"117","article-title":"Non\u2010convulsive status epilepticus: a prospective study in an adult general hospital","volume":"62","author":"Dunne JW","year":"1987","journal-title":"Q J Med"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00313944"},{"key":"e_1_2_1_18_2","first-page":"152","volume-title":"Typical absences and related epileptic syndromes","author":"Loiseau P","year":"1994"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.26.8.788"},{"key":"e_1_2_1_20_2","first-page":"392","article-title":"Carbamazepine\u2010induced seizures [abstract]","volume":"16","author":"Johnsen SD","year":"1984","journal-title":"Ann Neurol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(86)90074-3"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02549.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.11.2198"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1487"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198510103131503"},{"key":"e_1_2_1_26_2","first-page":"534","article-title":"Enhancement of absence with Tegretol [abstract]","volume":"26","author":"Sachdeo R","year":"1985","journal-title":"Epilepsia"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350616"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.11.10.912"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6974(05)80021-0"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.3.285"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1985.tb00900.x"},{"key":"e_1_2_1_32_2","first-page":"145","volume-title":"Typical absences and related epileptic syndromes","author":"Roger J","year":"1994"},{"key":"e_1_2_1_33_2","first-page":"37","article-title":"Genetic absence epilepsy in rats from Strasbourg\u2014a review","volume":"35","author":"Marescaux C","year":"1992","journal-title":"J Neural Transm Suppl"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1988.tb03732.x"},{"key":"e_1_2_1_35_2","first-page":"779","article-title":"Multiple actions of phenytoin on mouse spinal cord neurons in cell culture","volume":"227","author":"McLean MJ","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_36_2","first-page":"727","article-title":"Carbamazepine and 10,11\u2010epoxycarbamazepine produce use\u2010 and voltage\u2010dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture","volume":"238","author":"McLean MJ","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_37_2","first-page":"271","volume-title":"Antiepileptic drugs","author":"DeLorenzo RJ.","year":"1995"},{"key":"e_1_2_1_38_2","first-page":"107","volume-title":"Dynamic aspects of neocortical function","author":"Steriade M.","year":"1984"},{"key":"e_1_2_1_39_2","first-page":"547","volume-title":"Epileptic seizures and syndromes","author":"Avoli M","year":"1994"},{"key":"e_1_2_1_40_2","first-page":"107","volume-title":"Electrophysiology of epilepsy","author":"Gloor P.","year":"1984"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(84)90151-1"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1988.68.3.649"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1989.tb05300.x"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90335-2"},{"key":"e_1_2_1_45_2","first-page":"829","article-title":"Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells","volume":"266","author":"Lang DG","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(87)90990-5"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410250610"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1990.tb14095.x"},{"key":"e_1_2_1_49_2","first-page":"2432","article-title":"Effects of different classes of anti\u2010epileptic drugs on brain\u2010stem stimulation pathways","volume":"44","author":"Fromm GH.","year":"1985","journal-title":"Fed Proc"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00647273"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(85)90106-2"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90396-9"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90130-X"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91262-Y"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90623-C"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90164-7"},{"key":"e_1_2_1_57_2","first-page":"447","volume-title":"Idiopathic generalized epilepsies: clinical, experimental and genetic aspects","author":"Keane PE","year":"1994"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.63.5.622"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1998.tb15409.x"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01135.x"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(96)80110-5"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01332.x"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00265-8"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6554"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073897012001031"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1157.2000.tb00258.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1157.2000.tb00258.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:51:05Z","timestamp":1698569465000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1157.2000.tb00258.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["10.1111\/j.1528-1157.2000.tb00258.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb00258.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}